Avanos Medical AVNS Total Specialty Nutrition Systems — Research and development expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Avanos Medical in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avanos Medical's total specialty nutrition systems — research and development expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Avanos Medical's total specialty nutrition systems — research and development expenses?
- Avanos Medical (AVNS) reported total specialty nutrition systems — research and development expenses of -$3.7M in Q1 2026.
- How has Avanos Medical's total specialty nutrition systems — research and development expenses changed year-over-year?
- Avanos Medical's total specialty nutrition systems — research and development expenses increased by 9.8% year-over-year, from -$4.1M to -$3.7M.
- What is the long-term trend for Avanos Medical's total specialty nutrition systems — research and development expenses?
- Over 2 years (2023 to 2025), Avanos Medical's total specialty nutrition systems — research and development expenses has grown at a 7.0% compound annual growth rate (CAGR), from -$14.6M to -$16.7M.
- What does total specialty nutrition systems — research and development expenses mean?
- These are the costs incurred for the innovation, design, and clinical testing of new specialty nutrition products or improvements to existing medical devices. This investment is essential for maintaining long-term competitiveness and driving future revenue growth through product differentiation.